These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31591136)

  • 21. Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia.
    Nomoto M; Konopaske GT; Yamashita N; Aoki R; Jitsuki-Takahashi A; Nakamura H; Makihara H; Saito M; Saigusa Y; Nakamura F; Watanabe K; Baba T; Benes FM; Tobe BTD; Pernia CD; Coyle JT; Sidman RL; Hirayasu Y; Snyder EY; Goshima Y
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.
    Wilson SM; Khanna R
    Mol Neurobiol; 2015 Apr; 51(2):599-609. PubMed ID: 24944082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular dynamics simulations and in vitro analysis of the CRMP2 thiol switch.
    Möller D; Gellert M; Langel W; Lillig CH
    Mol Biosyst; 2017 Aug; 13(9):1744-1753. PubMed ID: 28726921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2.
    Varrin-Doyer M; Nicolle A; Marignier R; Cavagna S; Benetollo C; Wattel E; Giraudon P
    J Immunol; 2012 Feb; 188(3):1222-33. PubMed ID: 22227566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
    Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
    Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular pathophysiology of schizophrenia and preventive strategy in pubertal period].
    Itokawa M; Arai M; Ichikawa T; Miyashita M; Yoshikawa T; Okazaki Y; Miyata T
    Seishin Shinkeigaku Zasshi; 2011; 113(7):672-8. PubMed ID: 21882541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling.
    Garza JC; Qi X; Gjeluci K; Leussis MP; Basu H; Reis SA; Zhao WN; Piguel NH; Penzes P; Haggarty SJ; Martens GJ; Poelmans G; Petryshen TL
    Transl Psychiatry; 2018 Jul; 8(1):135. PubMed ID: 30046097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonyl stress in schizophrenia.
    Itokawa M; Miyashita M; Arai M; Miyata T
    Biochem Soc Trans; 2014 Apr; 42(2):468-72. PubMed ID: 24646262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canonical TGF-β Signaling Negatively Regulates Neuronal Morphogenesis through TGIF/Smad Complex-Mediated CRMP2 Suppression.
    Nakashima H; Tsujimura K; Irie K; Ishizu M; Pan M; Kameda T; Nakashima K
    J Neurosci; 2018 May; 38(20):4791-4810. PubMed ID: 29695415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteome-wide profiling of carbonylated proteins and carbonylation sites in HeLa cells under mild oxidative stress conditions.
    Bollineni RC; Hoffmann R; Fedorova M
    Free Radic Biol Med; 2014 Mar; 68():186-95. PubMed ID: 24321318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.
    Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB
    Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history.
    Toyosima M; Maekawa M; Toyota T; Iwayama Y; Arai M; Ichikawa T; Miyashita M; Arinami T; Itokawa M; Yoshikawa T
    Br J Psychiatry; 2011 Sep; 199(3):245-6. PubMed ID: 21881099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
    Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
    Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional protein kinase Cβ-mediated phosphorylation inhibits collapsin response-mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice.
    Yang X; Zhang X; Li Y; Han S; Howells DW; Li S; Li J
    J Neurochem; 2016 May; 137(3):446-59. PubMed ID: 26788931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRMP1 and CRMP2 have synergistic but distinct roles in dendritic development.
    Makihara H; Nakai S; Ohkubo W; Yamashita N; Nakamura F; Kiyonari H; Shioi G; Jitsuki-Takahashi A; Nakamura H; Tanaka F; Akase T; Kolattukudy P; Goshima Y
    Genes Cells; 2016 Sep; 21(9):994-1005. PubMed ID: 27480924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
    Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
    Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.
    Wang L; Ji S
    J Mol Neurosci; 2019 Nov; 69(3):391-398. PubMed ID: 31267313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collapsin response mediator protein 2 is involved in regulating breast cancer progression.
    Shimada K; Ishikawa T; Nakamura F; Shimizu D; Chishima T; Ichikawa Y; Sasaki T; Endo I; Nagashima Y; Goshima Y
    Breast Cancer; 2014 Nov; 21(6):715-23. PubMed ID: 23381229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.